Zoetis (ZTS) closed at $170.37 in the latest trading session, marking a +1.87% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.55%. At the same time, the Dow added 0.52% ...

Zoetis secured a USDA conditional license for its H5N2 avian flu vaccine for chickens, based on safety, purity, and serology-backed efficacy Over 150 million U.S. birds have been affected by ...

Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $74.8 billion ...

In its fourth quarter 2024 investor letter, Polen Focus Growth Strategy emphasized stocks such as Zoetis Inc. (NYSE:ZTS). Zoetis Inc. (NYSE: ZTS) is involved in the research, development ...

On Friday, the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE:ZTS) a conditional license for its Avian Influenza Vaccine, H5N2 Subtype ...

Peck graduated from Greenwich Academy in 1989. She became the company's CEO in 2020 after holding other leadership roles in strategy, operations and business development. “Kristin is a ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The company’s shares closed last Friday at $157.52.

The federal government granted animal health company Zoetis a conditional license for its avian influenza vaccine for use in chickens as bird flu outbreaks continue to devastate flocks across the ...

This month, the USDA granted a conditional license to Zoetis for its Avian Influenza Vaccine. "It shows promise. We hope that it works, in my hope, and I'm sure many others can use that to stop ...

As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine By India Edwards HealthDay Reporter TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...